This course has been designed to teach healthcare professionals (nephrologists, primary care physicians, endocrinologists, cardiologists, and physician assistants/nurse practitioners) about how to manage the risk of hyperkalemia in patients with diabetes and chronic kidney disease. 

It should take you approximately 60 minutes to complete.

Patients with these concurrent diseases are at high risk of developing hyperkalemia, and it can be a life-threatening condition. This course provides clinicians with the tools they need to both delay the onset of and manage elevated potassium levels. Elements discussed include: SGLT2 inhibitors, RAAS inhibitors including non-steroidal MRAs, low-potassium diets, and potassium binders.

This course has a 2-year expiry date of 10th October 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.

CME/CPD Information

This course has been accredited by the European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) with 1 European CME credit (ECMEC®).

This accreditation certifies the quality and relevance of the educational content.

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™.